LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

Home・Lista de Ações・Twist Bioscience Corp

Twist Bioscience Corp

Fechado

SetorSaúde

67.42 0.94

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

63.71

Máximo

Indicadores-chave
By Trading Economics
Rendimento	-14M -44M
Vendas	7M 111M
EPS	-0.71
Margem de lucro	-39.761
Funcionários	979
EBITDA	-16M -40M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	-4.29% downside

Dividendos
By Dow Jones
Próximos Ganhos	3 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	327M 3.8B
Abertura anterior	66.48
Fecho anterior	67.42

Sentimento de Notícias

By Acuity

34%

66%

79 / 344 Ranking em Healthcare

Twist Bioscience Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de jun. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Optimism Over AI Demand -- Market Talk

1 de jun. de 2026, 23:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Google Seeks $80 Billion for AI Buildout; Berkshire Will Buy $10 Billion Stake -- WSJ

1 de jun. de 2026, 23:37 UTC

Conversa de Mercado

Oil Edges Higher; Trump Seeks to Quell Israel-Hezbollah Conflict -- Market Talk

1 de jun. de 2026, 23:01 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 de jun. de 2026, 23:01 UTC

Conversa de Mercado

Dexus Stuck in 'Too Hard' Basket -- Market Talk

1 de jun. de 2026, 22:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1 de jun. de 2026, 22:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1 de jun. de 2026, 22:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Google Seeks to Raise $80 Billion for AI Infrastructure -- Update

1 de jun. de 2026, 21:55 UTC

Aquisições, Fusões, Aquisições de Empresas

Greg Abel's Week Is Off to Quite a Start -- WSJ

1 de jun. de 2026, 21:53 UTC

Conversa de Mercado

Strong Earnings Suppress Concerns About Oil Market -- Market Talk

1 de jun. de 2026, 21:22 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Berkshire's Abel Takes Big Swing With Back-to-Back Deals -- Market Talk

1 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

1 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

1 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

1 de jun. de 2026, 20:46 UTC

Aquisições, Fusões, Aquisições de Empresas

The Odds SpaceX Merges With Tesla Are Higher Than You Think -- Barrons.com

1 de jun. de 2026, 20:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Doesn't Expect Additional Divs in 2026

1 de jun. de 2026, 20:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Div Payable June 25 to Hldrs of Record June 11

1 de jun. de 2026, 20:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Declares $11 Special Div

1 de jun. de 2026, 20:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Completes Sale of Select Spectrum Assets to Verizon for $1B

1 de jun. de 2026, 19:40 UTC

Conversa de Mercado

Remittances to Mexico Rise for Third Straight Month -- Market Talk

1 de jun. de 2026, 19:28 UTC

Conversa de Mercado

BoC Official Reiterates Need to Improve Business Investment -- Market Talk

1 de jun. de 2026, 19:01 UTC

Conversa de Mercado

Oil Futures Rise On Concerns About U.S.-Iran Talks -- Market Talk

1 de jun. de 2026, 18:58 UTC

Conversa de Mercado

U.S. Natural Gas Futures Snap 3-Session Winning Streak -- Market Talk

1 de jun. de 2026, 18:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Stock Drops. Its Bargain-Priced Deal for Home Builder Fails to Impress Investors. -- Barrons.com

1 de jun. de 2026, 18:33 UTC

Conversa de Mercado

Mexican PMIs Show Sluggish Manufacturing in May -- Market Talk

1 de jun. de 2026, 18:32 UTC

Conversa de Mercado

Precious Metals Fall to Start June -- Market Talk

1 de jun. de 2026, 18:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Marsh McLennan Agency Completes Acquisition Of TriBridge Partners >MRSH

1 de jun. de 2026, 17:18 UTC

Conversa de Mercado

Global Asset Managers Accumulate Canadian Government Debt -- Market Talk

1 de jun. de 2026, 17:18 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 de jun. de 2026, 17:10 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Salesforce Estimated to Get $225M Sales Boost From Contentful -- Market Talk

Comparação entre Pares

Variação de preço

Twist Bioscience Corp Previsão

Preço-alvo

By TipRanks

-4.29% parte inferior

Previsão para 12 meses

Média 64 USD -4.29%

Máximo 70 USD

Mínimo 56 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Twist Bioscience Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

Comprar

Manter

Vender

Com base em 7 analistas que deram avaliações de ações para Twist Bioscience Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

79 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.